Risk factor
High price volatility
Profitability factor
Greatly undervalued vs peers
About
Huons Global Co., Ltd., headquartered in Seongnam, South Korea, is a healthcare enterprise dedicated to delivering a wide array of medical solutions for human well-being, serving both domestic and international markets. The company manufactures and distributes an extensive portfolio of pharmaceutical products. This includes oral solid medications addressing diverse therapeutic areas such as cardiovascular health, metabolic disorders, pain and inflammation, digestive issues, respiratory conditions, infections, urogenital ailments, and general wellness. Their injectable offerings are even more comprehensive, encompassing anesthetics, analgesics, anti-inflammatory agents, muscle relaxants, hormones, enzymes, minerals, antibiotics, and treatments for metabolic, circulatory, and respiratory systems, among many other specialized applications. Beyond pharmaceuticals, Huons Global also provides medical devices, ophthalmic preparations, and biological products. Founded in 1965, the company operated as Huons Co., Ltd. until its rebranding to Huons Global Co., Ltd. in June 2016.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap'